摘要
糖尿病视网膜病变是严重的致盲眼病 ,氨基胍通过抑制蛋白非酶糖基化终末产物形成、一氧化氮合酶活性、对半卡巴肼敏感的胺氧化酶活性、毛细血管内白细胞粘滞、血管内皮生长因子以及抑制醛糖还原酶。
Diabetic retinopathy is among the main causes of blindness.Aminoguanidine has improvement on diabetic retinopathy by ways of inhibiting advanced glycation end products, capillary leukostasis,nitricoxide synthase, semicarbazide sensitive amine oxidase, vascular endothelial growth factor, aldose reductase and inhibiting oxidative modification of low density lipoprotein.
出处
《眼科新进展》
CAS
2002年第3期206-208,共3页
Recent Advances in Ophthalmology
基金
国家自然科学基金资助 (No:3 9970 783 )~~
